Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBIRI + FOLFOX in Colorectal Cancer With Liver Metastases
NCT01839877Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- May 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of DEBIRI in colorectal cancer (CRC), liver metastasis, sponsored by Fédération Francophone de Cancérologie Digestive. Started May 2013; status: completed.
02
Drugs
DEBIRI
03
Conditions
colorectal cancer (CRC)liver metastasis
Beyond the preview
Go deeper on NCT01839877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839877.